Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
is a consultant/advisory board member for endocrinological adverse events at Ono Pharmaceutical Company and Bristol-Myers Squibb, and receives fees for presentations, consulting and advising, and the writing of published materials from Ono Pharmaceutical Company, Bristol-Myers Squibb and MSD K.K
BCL-2: B-cell lymphoma 2
Liraglutide improved inflammation via mediating IL-23/Th-17 pathway in obese diabetic mice with psoriasiform skin
Additionally, serelaxin-treated patients had a higher attenuation of congestion signs (oedema, rales, jugular venous pressure) compared to placebo, at days 5 and 14, as well as decreased worsening heart failure (WHF) at day 5 [22]
Proteomics of bronchial biopsies: galectin-3 as a predictive biomarker of airway remodelling modulation in omalizumab-treated severe asthma patients
Molecular recognition and activation of the prostacyclin receptor by anti-pulmonary arterial hypertension drugs
US$ 22.80
US$ 26.19
US$ 24.29
US$ 22.93
US$ 23.97
